INTEGRATIVE CANCER CARE • SCOTTSDALE, ARIZONA
Alternative Cancer Treatments & Integrative Therapies
Explore selected physician-directed therapies used at Sunridge Medical for cancer patients seeking a more individualized approach. Treatment recommendations depend on diagnosis, prior care, laboratory findings, current medications, goals and clinical judgment.
✓ Onsite nursing & infusion rooms ✓ Individualized plans ✓ Coordinated care
Speak With Our Cancer Patient Care Team
Tell us where you are in your cancer journey. Our Patient Care Team can answer questions and help determine the next step.
See how Sunridge reviews the whole case before recommending a treatment plan.
Review therapies that may be considered for some cancer patients.
Prepare records, questions and travel details before speaking with the care team.
WHAT MAKES SUNRIDGE DIFFERENT
Cancer care that happens here
Sunridge is a treatment facility—not simply an office that recommends products for patients to use at home. Our Scottsdale clinic includes nursing staff, infusion rooms and space for patients to receive physician-directed therapies onsite.
Some local and out-of-town patients follow more concentrated schedules while they are in Scottsdale. Frequency and duration vary according to clinical needs, treatment tolerance, travel plans and the medical team’s recommendations.
Onsite treatment support
Nursing oversight, infusion rooms and individualized scheduling in Scottsdale.
FROM REVIEW TO TREATMENT
How treatment planning works
There is no universal protocol for every cancer patient. The process begins by understanding the person, the diagnosis and the care already underway.
01
Detailed case review
Records, imaging, pathology, laboratory data, treatment history, medications and current goals are reviewed before recommendations are made.
02
Individualized planning
Potential conventional, nutritional, metabolic, immune-supportive and complementary strategies are considered together.
03
Treatment at the clinic
When appropriate, selected treatments are delivered onsite with nursing support and physician oversight.
04
Monitoring and reassessment
Symptoms, laboratory values, treatment tolerance and changing priorities help guide adjustments over time.
SELECTED TREATMENT OPTIONS
Some of the treatments we use for cancer patients
This is not a complete list, and inclusion here does not mean a therapy is appropriate for every patient. Select a treatment to review its potential role, available evidence, safety considerations and questions to discuss with the medical team.
Physician-directed intravenous vitamin C may be considered within an individualized cancer-care plan after appropriate screening and laboratory review.
Mistletoe therapy may be incorporated as a supportive integrative option, with formulation and scheduling determined by the medical team.
Learn how IPT is approached, what screening may be required and why treatment decisions must be individualized.
Explore immune-focused treatment concepts, biomarker considerations and supportive strategies used within coordinated cancer care.
Glutathione may be considered in carefully timed supportive protocols based on treatment goals, medications and clinical status.
Review how curcumin is discussed in integrative oncology, including formulation, evidence, interactions and medical oversight.
Alpha lipoic acid may be evaluated as part of a broader metabolic and supportive plan after medication and laboratory review.
Learn about artemisinin research, clinical limitations, safety questions and why professional guidance is essential.
Dichloroacetate is an investigational metabolic therapy that requires careful evaluation, monitoring and discussion of uncertainty.
Review ozone and oxidative therapy concepts, limits of evidence, safety considerations and physician-directed use.
Explore the rationale, available evidence and clinical questions considered before Poly-MVA is included in a plan.
Resveratrol may be discussed in the context of nutrition, metabolism, drug interactions and individualized supportive care.
A physician-guided overview of redox-focused therapies, their proposed roles, safety considerations and monitoring.
Sunridge uses onsite infusion rooms and nursing oversight for selected intravenous therapies within individualized plans.
Nutrition and supplementation are reviewed alongside diagnosis, appetite, laboratory findings, medications and treatment tolerance.
Supportive care may focus on strength, nutrition, symptoms, laboratory trends and recovery goals after conventional treatment.
THE LIST CONTINUES
Additional therapies and supportive care
Depending on the case, the medical team may also discuss other intravenous nutrients, metabolic support, immune assessment, molecular hydrogen inhalation, personal cancer wellness programs, recovery support and additional therapies available through Sunridge. Availability, formulation and scheduling can change.
The safest starting point is a case review—not selecting a therapy from a list.
EXPLORE BY DIAGNOSIS
Cancer-specific care pages
Treatment planning depends heavily on cancer type, stage, biomarkers, previous therapies and current health. Use these pages to begin with diagnosis-specific information.
HELPFUL NEXT STEPS
Planning, support and patient resources
Treatment decisions are only one part of cancer care. These guides can help with records, second opinions, travel, finances and practical planning.
BEFORE YOU BEGIN
Common questions about care at Sunridge
Does Sunridge replace my oncologist?
Sunridge can work alongside outside oncologists and specialists when appropriate. Coordination depends on the patient’s situation, preferences and the clinicians involved.
Are all treatments appropriate for every cancer patient?
No. Diagnosis, stage, biomarkers, treatment history, medications, laboratory findings and current health all affect what may be reasonable or safe.
Can out-of-town patients receive treatment at Sunridge?
Yes. Some patients travel to Scottsdale and follow concentrated schedules while they are in town. Timing and frequency are determined after medical review.
What should I send before a consultation?
Helpful records often include pathology, imaging reports, recent laboratory results, medication and supplement lists, treatment summaries and a short list of priorities or questions.
EVIDENCE, SAFETY & EXPECTATIONS
A careful, medically reviewed approach
Integrative and complementary cancer therapies vary in their evidence, potential benefits, risks and interactions. Information on this page is educational and does not promise a result or replace individualized medical advice. Patients should not stop or change oncology treatment without speaking with the clinicians directing their care.
For broader research context, review this systematic review of complementary and alternative medicine in oncology.
Research by Medicine and Integrative Treatment
Cancer and treatment research libraries
Browse by cancer type
- Bladder Cancer research 18 studies
- Bone Cancer research 21 studies
- Brain Cancer research 35 studies
- Breast Cancer research 33 studies
- Cervical Cancer research 19 studies
- Cholangiocarcinoma research 15 studies
- Colorectal Cancer research 33 studies
- Esophageal Cancer research 20 studies
- Gastric Cancer research 30 studies
- Head and Neck Cancer research 86 studies
- Kidney Cancer research 7 studies
- Leukemia research 27 studies
- Liver Cancer research 27 studies
- Lung Cancer research 19 studies
- Lymphoma research 21 studies
- Melanoma research 30 studies
- Neuroendocrine Cancer research 6 studies
- Ovarian Cancer research 25 studies
- Pancreatic Cancer research 20 studies
- Prostate Cancer research 30 studies
- Sarcoma research 27 studies
- Skin Cancer research 6 studies
- Testicular Cancer research 11 studies
- Thyroid Cancer research 14 studies
- Uterine Cancer research 13 studies
- Stage 4 and Metastatic Cancer research 80 studies
Browse by treatment or substance
- Alpha-lipoic acid 1 studies
- Amygdalin / laetrile 4 studies
- Artemisinin / dihydroartemisinin 50 studies
- Berberine 12 studies
- Curcumin 78 studies
- Deuterium-depleted water 10 studies
- Dichloroacetate (DCA) 2 studies
- EGCG 27 studies
- Enzyme therapy 1 studies
- Fenbendazole 4 studies
- Germanium 1 studies
- Ginsenosides / Careseng 35 studies
- Glutathione 14 studies
- Inositol / IP6 2 studies
- Insulin potentiation therapy 5 studies
- Ivermectin 10 studies
- Low-dose naltrexone 11 studies
- Melatonin 41 studies
- Mistletoe 6 studies
- Ozone therapy 1 studies
- Poly-MVA 1 studies
- Probiotics / microbiome 14 studies
- Quercetin 37 studies
- Rapamycin / sirolimus 14 studies
- Resveratrol 45 studies
- Silymarin / silibinin 13 studies
- Sodium bicarbonate 5 studies
- Sodium selenite 6 studies
- Sulforaphane 15 studies
- Vitamin C / ascorbate 20 studies
- Vitamin D / calcitriol 14 studies